Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Breast Carcinoma In Situ × Fulvestrant × Clear all

Sponsor

Conditions

Breast Neoplasms 93 Neoplasms 12 Neoplasm Metastasis 12 Hereditary Sensory and Autonomic Neuropathies 3 Advanced Breast Cancer 3 Recurrence 2 Prostatic Neoplasms 2 Ovarian Neoplasms 2 Multiple Endocrine Neoplasia Type 1 2 Endometrial Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Breast Neoplasms, Male 2 Solid Malignancies 1 Recurrent Uterine Corpus Carcinoma 1 Neoplasms by Site 1 Lymphoma, Non-Hodgkin 1 Lymphoma 1 Lethal Congenital Contracture Syndrome 2 1 Hyperglycemia 1 Hormone Receptor Positive HER-2 Negative Breast Cancer 1 Hormone Receptor Positive Breast Cancer 1 HER2-positive Breast Cancer 1 Exanthema 1 Estrogen Receptor-positive Breast Cancer 1 Carcinoma, Ovarian Epithelial 1 Breast Diseases 1 Breast Cancer Metastatic 1 Anatomic Stage IV Breast Cancer AJCC v8 1 Advanced Metastatic Breast Cancer 1 Advanced Cancer 1

Interventions

Tamoxifen 3 Taxes 2 Simvastatin 2 Radiotherapy 2 Radiation 2 Paclitaxel 2 Gene Expression Profiling 2 Chemotherapy, Adjuvant 2 Celecoxib 2 telapristone acetate 1 poly(I).poly(c12,U) 1 oxybutynin 1 liposomal doxorubicin 1 exemestane 1 dexamethasone acetate 1 dexamethasone 21-phosphate 1 auricularum 1 Yoga 1 Sugars 1 Sentinel Lymph Node Biopsy 1 Ranitidine 1 Radiation Dose Hypofractionation 1 Pharmacogenomic Testing 1 Neoadjuvant Therapy 1 Naltrexone 1 Monitoring, Physiologic 1 Metformin 1 Mastectomy, Segmental 1 Mastectomy 1 Magnetic Resonance Spectroscopy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡